These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15306236)

  • 1. Expression levels of cytoskeletal proteins indicate pathological aging of S100B transgenic mice: an immunohistochemical study of MAP-2, drebrin and GAP-43.
    Shapiro LA; Whitaker-Azmitia PM
    Brain Res; 2004 Sep; 1019(1-2):39-46. PubMed ID: 15306236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased clusterin expression in old but not young adult S100B transgenic mice: evidence of neuropathological aging in a model of Down Syndrome.
    Shapiro LA; Marks A; Whitaker-Azmitia PM
    Brain Res; 2004 Jun; 1010(1-2):17-21. PubMed ID: 15126113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice overexpressing the neurotrophic factor S-100 beta show neuronal cytoskeletal and behavioral signs of altered aging processes: implications for Alzheimer's disease and Down's syndrome.
    Whitaker-Azmitia PM; Wingate M; Borella A; Gerlai R; Roder J; Azmitia EC
    Brain Res; 1997 Nov; 776(1-2):51-60. PubMed ID: 9439795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation.
    Deloulme JC; Raponi E; Gentil BJ; Bertacchi N; Marks A; Labourdette G; Baudier J
    Mol Cell Neurosci; 2004 Dec; 27(4):453-65. PubMed ID: 15555923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced susceptibility of S-100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human beta-amyloid.
    Craft JM; Watterson DM; Marks A; Van Eldik LJ
    Glia; 2005 Aug; 51(3):209-16. PubMed ID: 15810011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo post-transcriptional regulation of GAP-43 mRNA by overexpression of the RNA-binding protein HuD.
    Bolognani F; Tanner DC; Merhege M; Deschênes-Furry J; Jasmin B; Perrone-Bizzozero NI
    J Neurochem; 2006 Feb; 96(3):790-801. PubMed ID: 16405504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced calcium transients in glial cells in neonatal cerebellar cultures derived from S100B null mice.
    Xiong Z; O'Hanlon D; Becker LE; Roder J; MacDonald JF; Marks A
    Exp Cell Res; 2000 Jun; 257(2):281-9. PubMed ID: 10837142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial and temporal expression of S100B in cells of oligodendrocyte lineage.
    Hachem S; Aguirre A; Vives V; Marks A; Gallo V; Legraverend C
    Glia; 2005 Aug; 51(2):81-97. PubMed ID: 15782413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-differences in age-related cognitive decline in C57BL/6J mice associated with increased brain microtubule-associated protein 2 and synaptophysin immunoreactivity.
    Benice TS; Rizk A; Kohama S; Pfankuch T; Raber J
    Neuroscience; 2006; 137(2):413-23. PubMed ID: 16330151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte-neuron vulnerability to prenatal stress in the adult rat brain.
    Barros VG; Duhalde-Vega M; Caltana L; Brusco A; Antonelli MC
    J Neurosci Res; 2006 Apr; 83(5):787-800. PubMed ID: 16493669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the full-length neurotrophin receptor trkB regulates the expression of plasticity-related genes in mouse brain.
    Koponen E; Lakso M; Castrén E
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):81-94. PubMed ID: 15519679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100-mediated signal transduction in the nervous system and neurological diseases.
    Zimmer DB; Chaplin J; Baldwin A; Rast M
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):201-14. PubMed ID: 16171556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease.
    Harigaya Y; Shoji M; Shirao T; Hirai S
    J Neurosci Res; 1996 Jan; 43(1):87-92. PubMed ID: 8838578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization.
    Ramos AJ; Rubio MD; Defagot C; Hischberg L; Villar MJ; Brusco A
    Brain Res; 2004 Dec; 1030(2):201-20. PubMed ID: 15571670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental changes in content of glial marker proteins in rats exposed to protein malnutrition.
    Feoli AM; Leite MC; Tramontina AC; Tramontina F; Posser T; Rodrigues L; Swarowsky A; Quincozes-Santos A; Leal RB; Gottfried C; Perry ML; Gonçalves CA
    Brain Res; 2008 Jan; 1187():33-41. PubMed ID: 18021757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogenetic changes in serum S100B in Down syndrome patients.
    Netto CB; Portela LV; Ferreira CT; Kieling C; Matte U; Felix T; da Silveira TR; Souza DO; Gonçalves CA; Giugliani R
    Clin Biochem; 2005 May; 38(5):433-5. PubMed ID: 15820773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct regulation of brain-derived neurotrophic factor and noradrenaline in S100B knockout mice.
    Schulte-Herbrüggen O; Hörtnagl H; Ponath G; Rothermundt M; Hellweg R
    Neurosci Lett; 2008 Sep; 442(2):100-3. PubMed ID: 18638525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain area- and isoform-specific inhibition of synaptic plasticity by apoE4.
    Levi O; Jongen-Relo AL; Feldon J; Michaelson DM
    J Neurol Sci; 2005 Mar; 229-230():241-8. PubMed ID: 15760646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arundic Acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic mice.
    Mori T; Town T; Tan J; Yada N; Horikoshi Y; Yamamoto J; Shimoda T; Kamanaka Y; Tateishi N; Asano T
    J Pharmacol Exp Ther; 2006 Aug; 318(2):571-8. PubMed ID: 16709678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage.
    Raponi E; Agenes F; Delphin C; Assard N; Baudier J; Legraverend C; Deloulme JC
    Glia; 2007 Jan; 55(2):165-77. PubMed ID: 17078026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.